Top

Annals of Hematology

Published in:

Open Access 01-10-2016 | Letter to the Editor

AOHE: manuscript AOHE-D-16-00564 paroxysmal nocturnal hemoglobinuria with autoimmune hemolytic anemia following eculizumab therapy—with large granular lymphocytic leukemia

Authors: Nathan Visweshwar, Michael Jaglal, Cassie Booth, Patrick Griffin, Damian Laber

Published in: Annals of Hematology | Issue 10/2016

Excerpt

Dear Editor, …

Yamada N et al (1995) Somatic mutations of the PIG-A gene found in Japanese patients with paroxysmal nocturnal hemoglobinuria. Blood 85(4):885–892PubMed

Navenot JM et al (1993) Rapid diagnosis of paroxysmal nocturnal hemoglobinuria by gel test agglutination. Rev Fr Transfus Hemobiol 36(2):135–147PubMed

Nakayama H et al (2016) Eculizumab dosing intervals longer than 17 days may be associated with greater risk of breakthrough hemolysis in patients with paroxysmal nocturnal hemoglobinuria. Biol Pharm Bull 39(2):285–288CrossRefPubMed

Risitano AM et al (2009) Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab. Blood 113(17):4094–4100CrossRefPubMed

Hochsmann B et al (2012) Paroxysmal nocturnal haemoglobinuria treatment with eculizumab is associated with a positive direct antiglobulin test. Vox Sang 102(2):159–166CrossRefPubMed

Luzzatto L (2016) Recent advances in the pathogenesis and treatment of paroxysmal nocturnal hemoglobinuria. F1000Res p 5. doi:10.12688/f1000research.7288.1

Gargiulo L et al (2007) Highly homologous T-cell receptor beta sequences support a common target for autoreactive T cells in most patients with paroxysmal nocturnal hemoglobinuria. Blood 109(11):5036–5042CrossRefPubMed

Gargiulo L et al (2013) Glycosylphosphatidylinositol-specific, CD1d-restricted T cells in paroxysmal nocturnal hemoglobinuria. Blood 121(14):2753–2761CrossRefPubMed

Title: AOHE: manuscript AOHE-D-16-00564 paroxysmal nocturnal hemoglobinuria with autoimmune hemolytic anemia following eculizumab therapy—with large granular lymphocytic leukemia
Authors: Nathan Visweshwar
Michael Jaglal
Cassie Booth
Patrick Griffin
Damian Laber
Publication date: 01-10-2016
Publisher: Springer Berlin Heidelberg
Published in: Annals of Hematology / Issue 10/2016
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI: https://doi.org/10.1007/s00277-016-2752-5

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

AOHE: manuscript AOHE-D-16-00564 paroxysmal nocturnal hemoglobinuria with autoimmune hemolytic anemia following eculizumab therapy—with large granular lymphocytic leukemia

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 10/2016

Cost analysis of a randomized stem cell mobilization study in multiple myeloma

Extraosseous plasmacytoma in the nasal cavity after rituximab therapy against pulmonary MALT lymphoma

Similar epidemiological trends of pre-neoplastic precursors and their respective lymphoid malignancies in Taiwan

Detection of non-CLL-like monoclonal B cell lymphocytosis increases dramatically in the very elderly, while detection of CLL-like populations varies by race: findings in a multiethnic population-based cohort of elderly women

Allogeneic bone marrow transplantation for therapy-related acute lymphocytic leukemia after autologous hematopoietic stem cell transplantation for multiple myeloma

Clinical characteristics and risk factors of Intracranial hemorrhage in patients following allogeneic hematopoietic stem cell transplantation

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page